Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas

NCT03460782 is registered in ClinicalTrials.gov with Center Trials & Treatment as lead sponsor.

NCT NCT03460782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03460782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas
Lead sponsor
Center Trials & Treatment
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, glioma of brain